Why the study?
Should routine childhood vaccination in the United States transition to greater reliance on Inactivated Poliovirus Vaccine (IPV) over Oral Poliovirus Vaccine (OPV)?
Should routine childhood vaccination in the United States transition to greater reliance on Inactivated Poliovirus Vaccine (IPV) over Oral Poliovirus Vaccine (OPV)?
New guidelines recommend transitioning from OPV to IPV for routine childhood polio vaccination in the United States.
Answers are grounded in this paper and cite their sources.
Clinicians should phase IPV into US childhood schedules over 3-5 years; reinforces global eradication by minimizing vaccine-derived poliovirus risks.
Until worldwide eradication of poliomyelitis is achieved, vaccination with poliovirus vaccines is the only means for providing population and individual immunity to polioviruses. The ACIP, AAP, and AAFP support the global poliomyelitis eradication initiative, and have recommended a transition policy that will increase use of IPV and decrease use of OPV during the next 3 to 5 years.
No takes yet. Share an insight, caveat, or question.
Prevots et al. (1997) studied this question. New routine childhood vaccination policies for poliomyelitis recommend a transition to increase use of inactivated poliovirus vaccine and decrease oral poliovirus vaccine over 3 to 5 years.
Synapse has enriched 10 related papers. Consider them for comparative context: